These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20636331)

  • 1. Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.
    Kramer V; Herth MM; Santini MA; Palner M; Knudsen GM; Rösch F
    Chem Biol Drug Des; 2010 Oct; 76(4):361-6. PubMed ID: 20636331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET.
    Herth MM; Kramer V; Piel M; Palner M; Riss PJ; Knudsen GM; Rösch F
    Bioorg Med Chem; 2009 Apr; 17(8):2989-3002. PubMed ID: 19329329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
    Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
    Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-labeling and evaluation of novel MDL 100907 derivatives as potential 5-HT2A antagonists for molecular imaging.
    Debus F; Herth MM; Piel M; Buchholz HG; Bausbacher N; Kramer V; Lüddens H; Rösch F
    Nucl Med Biol; 2010 May; 37(4):487-95. PubMed ID: 20447561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis and biological activities of new 5-HT2A selective ligands--N-substituted-piperidinyl-4-phenylthioether and sulfone derivatives].
    Wang H; Wen R; Huang L; Bi R; Tan PZ
    Yao Xue Xue Bao; 2001 Apr; 36(4):274-7. PubMed ID: 12580055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total synthesis and evaluation of [18F]MHMZ.
    Herth MM; Debus F; Piel M; Palner M; Knudsen GM; Lüddens H; Rösch F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1515-9. PubMed ID: 18187324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary in vivo and ex vivo evaluation of the 5-HT2A imaging probe [(18)F]MH.MZ.
    Herth MM; Piel M; Debus F; Schmitt U; Lüddens H; Rösch F
    Nucl Med Biol; 2009 May; 36(4):447-54. PubMed ID: 19423013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Congy C; Pointeau P; Vidal H; Brelière JC; Le Fur G
    Life Sci; 1994; 54(2):119-27. PubMed ID: 8277817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein influence on the brain uptake of a 5-HT(2A) ligand: [(18)F]MH.MZ.
    Schmitt U; Lee DE; Herth MM; Piel M; Buchholz HG; Roesch F; Hiemke C; Lueddens H; Debus F
    Neuropsychobiology; 2011; 63(3):183-90. PubMed ID: 21304228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization.
    Thomsen WJ; Grottick AJ; Menzaghi F; Reyes-Saldana H; Espitia S; Yuskin D; Whelan K; Martin M; Morgan M; Chen W; Al-Shamma H; Smith B; Chalmers D; Behan D
    J Pharmacol Exp Ther; 2008 May; 325(2):577-87. PubMed ID: 18252809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
    Deng X; Guo L; Xu L; Zhen X; Yu K; Zhao W; Fu W
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3970-4. PubMed ID: 26227779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential modes of interaction of 9-aminomethyl-9,10-dihydroanthracene (AMDA) derivatives with the 5-HT2A receptor: a ligand structure-affinity relationship, receptor mutagenesis and receptor modeling investigation.
    Runyon SP; Mosier PD; Roth BL; Glennon RA; Westkaemper RB
    J Med Chem; 2008 Nov; 51(21):6808-28. PubMed ID: 18847250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
    Gilbertson SR; Chen YC; Soto CA; Yang Y; Rice KC; Cunningham KA; Anastasio NC
    Bioorg Med Chem Lett; 2018 May; 28(8):1381-1385. PubMed ID: 29555153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.
    Kapadia N; Harding WW
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3451-4. PubMed ID: 26227772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulations and docking studies on 3D models of the heterodimeric and homodimeric 5-HT(2A) receptor subtype.
    Bruno A; Beato C; Costantino G
    Future Med Chem; 2011 Apr; 3(6):665-81. PubMed ID: 21554074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
    Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
    Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new class of arylpiperazine derivatives: the library synthesis on SynPhase lanterns and biological evaluation on serotonin 5-HT(1A) and 5-HT(2A) receptors.
    Zajdel P; Subra G; Bojarski AJ; Duszyńska B; Pawłowski M; Martinez J
    J Comb Chem; 2004; 6(5):761-7. PubMed ID: 15360211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.